Skip to main content
User Image

الدكتور مساعد بن علي الحدب الشمري

Assistant Professor

وكيل كلية الصيدلة للدراسات العليا والبحث العلمي

كلية الصيدلة
Building 23, Second floor, Room 1A 96, 2B 100, 2B 109, Lab 2B 107/83/64
cv

الدكتور مساعد بن علي الحدب الشمري

Bio
Musaad Alshammari received his Bachelor’s degree in Pharmaceutical Sciences from King Saud University. After graduation, Musaad worked as a teaching assistant in the Department of Pharmacology and Toxicology at King Saud University. In August 2011, Musaad enrolled in Pharmacology and Toxicology Graduate Program at the University of Texas Medical Branch in Galveston, Texas to begin his doctoral research. In Dr. Laezza's laboratory, Musaad’s project primarily emphasizes on the role of the intracellular fibroblast growth factor 14 (iFGF14) in regulating adult hippocampal neurogenesis. In 2016, Musaad earned his Ph.D. in Pharmacology and Toxicology from University of Texas Medical Branch. He has several publications in peer-reviewed journals. Now, Dr. Alshammari works as an assistant professor in King Saud University. Also, he serves as a Director of Innovation Unit in Pharmacy College at KSU.

malshammari@ksu.edu.sa
+966114677183



CV Text

Musaad Ali Alshammari, PhD

Assistant Professor and Vice Dean of Graduate Studies and Scientific Research
 

Department of Pharmacology and Toxicology
College of Pharmacy, King Saud University
 
Location:  Building 23, Second floor, Room 2B 100, Lab 2B 107/83/64
Phone: + (966) 11 4677183
Fax: + (966) 11 4677200
Email: malshammari@ksu.edu.sa
Web: fac.ksu.edu.sa/malshammari
Mailing Address
Department of Pharmacology and Toxicology
College of Pharmacy, King Saud University
P.O. Box 2457, Riyadh 11451, Saudi Arabia

Education

  • Ph.D. in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA. Mentor: Dr. Fernanda Laezza. (2011- 2016)
  • Bachelor’s Degree in Pharmaceutical Sciences, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. (2002- 2008)

Professional Experience

  • Vice Dean of Graduate Studies and Scientific Research, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. (Nov. 2019-Present).
  • Chair, Pharmacology and Toxicology Dept., Riyadh, Saudi Arabia. (May. 2018-Nov. 2019)
  • Director of Laboratories and Risk Management Unit in College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. (Dec. 2017-Present)
  • Director of Innovation Unit in College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. (Oct. 2016-Present)
  • Assistant professor, King Saud University, Pharmacology and Toxicology Dept., Riyadh, Saudi Arabia. (May. 2016-Present)
  • Teaching Assistant in King Saud University, Collage of Pharmacy, Pharmacology and Toxicology Department, Riyadh, Saudi Arabia. (May. 2008-Aug. 2009)
  • Pharmacist in Saudi Drug and Food Authority (SFDA), Pharmacovigilance Department. Riyadh, Saudi Arabia. (Mar. 2008-May. 2008)
  • Internship in King Fahad Medical City, Riyadh, Saudi Arabia. (Sep. 2007-Dec. 2007)

Research Interests
Identify the best therapeutic intervention for neurological and psychiatric disorders using translational approaches including, genetically and pharmacologically diseased-based animal models.
Goals
Understand the biology of pathological dysfunctions in brain disorders such as depression, autism, anxiety, pain, and attention deficit hyperactivity disorder (ADHD), schizophrenia, Alzheimer, and epilepsy.
Identify a biological link between CNS disorders and metabolic diseases such as diabetes and obesity.
Characterize signaling pathways critically involved in brain disorders.
Identify a potential biomarker and drug target / examine these drug targets.
Area of Research
Currently, my work centers on understanding the role of the molecular mechanisms underlying adult neural stem cells development in the adult mammalian brain. I am interested in identifying a novel regulator of adult neurogenesis that may be the key molecule in the pathogenesis of major neuropsychiatric disorders.
 
Chair/member of Master’s Thesis and PhD Dissertation Supervisory Committee:
Spring 2018                            Member of Ali Alshahrani Master’s Thesis examination committee

JOURNAL REVIEWER FOR:
Molecular Neurobiology

FELLOWSHIPS AND SCHOLARSHIPS
Aug. 2011 Ph.D. Scholarship from the Government of Saudi Arabia. King Saud University. 

HONORS/AWARDS
Sep. 2015 First Prize award at the NeuroRegeneration Collaborative Symposium, Rice University.
Apr. 2015 Travel scholarship from the Austin Conference on Learning & Memory, The University of Texas at Austin.

PUBLISHED:
ARTICLES IN PEER-REVIEWED JOURNALS:

  1. Musaad A. Alshammari, Mohammad R. Khan, Fawaz Alasmari, Abdulaziz O. Alshehri, Rizwan Ali, Mohamed Boudjelal, Khalid A. Alhosaini, Abdurahman Niazy, and Tahani Alshammari (2019). Changes in the Fluorescence Tracking of NaV1.6 Protein Expression in a BTBR T+Itpr3tf/J Autistic Mouse Mode. Neural Plasticity. https://doi.org/10.1155/2019/4893103. Impact Factor 3.6
  2. Tahani K. Alshammari, Hajar Alghamdi, Thomas Green, Abdulrahman Niazi, Lama Alkahdar, Nouf Alrasheed, Khalid Alhosaini, Mohammed Alswayyed, Ramesh Elango, Fernanda Laezza, Musaad A. Alshammari, Hazar Yacoub (2019). Assessing the Role of Toll-like Receptor in Isolated, Standard and Enriched Housing Conditions. PlosOne. https://doi.org/10.1371/journal.pone.0222818. Impact Factor 2.77
  3. Tahani K. Alshammari, Hajar Alghamdi, Lama F. Alkhader, Qamra Alqahtani, Nouf M. Alrasheed, Hazar Yacoub, Nora Alnaem, Maha AlNakiyah, Musaad A. Alshammari (2019). Analysis of the Molecular and Behavioral Effects of Acute Social Isolation on Rats. Behavioural Brain Research. doi.org/10.1016/j.bbr.2019.112191. Impact Factor 2.77
  4. Fawaz Alasmari, Musaad A. Alshammari, Abdullah F. Alasmari, Wael A. Alanazi, and Khalid Alhazzani (2018). Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism. BioMed Research International. doi.org/10.1155/2018/3087475. Impact Factor 2.93
  5. Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al-Harbi, Sabry M. Attia, Musaad A. Alshammari, Khalid S. Alzahrani, Saleh A. Bakheet (2018). Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T + tf/J mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. doi.org/10.1016/j.pnpbp.2018.09.012. Impact Factor 3.9
  6. Federico Scala, Miroslav N. Nenov1, Elizabeth Crofton, Aditya K. Singh, Oluwarotimi Folorunso, Yafang Zhang, Brent C. Chesson, Norelle C. Wildburger, Thomas F. James, Musaad A. Alshammari, Tahani K. Alshammari, Hannah Elfrink, Claudio Grassi, James M. Kasper, Ashley E. Smith1, Jonathan D. Hommel, Cheryl F. Lichti1, Jai S. Rudra, Marcello D'Ascenzo, Thomas A. Green and Fernanda Laezza (2018). Environmental enrichment and social isolation mediate neuroplasticity of medium spiny neurons through the GSK3 pathway. Cell Reports. doi. 10.1016/j.celrep.2018.03.062 Impact Factor 8.7
  7. Sheikh F. Ahmad, Mushtaq A. Ansari, Ahmed Nadeem, Saleh A. Bakheet, Mohammad Z.Alzahrani, Musaad A. Alshammari, Wael A. Alanazi, Abdullah F. Alasmari, Sabry M. Attiaab (2018). Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T+ Itpr3tf/J autistic mice. European Journal of Pharmacology. doi. 10.1016/j.ejphar.2018.04.008. Impact Factor 2.9
  8. Sheikh F. Ahmad, Mushtaq A. Ansari, Ahmed Nadeem, Saleh A. Bakheet, Musaad A.Alshammari, Mohammad R. Khan, Abdulaziz M. S. Alsaad, Sabry M.Attia (2018). BS3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T+ Itpr3tf/J mice. Cellular Signalling. doi.org/10.1016/j.cellsig.2018.09.006 Impact Factor 4.07
  9. Sheikh F. Ahmad, Mushtaq A. Ansari, Ahmed Nadeem, Saleh A. Bakheet, Musaad A. Alshammari, Sabry M. Attiaab (2018). Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism. Brain Research Bulletin. doi.org/10.1016/j.brainresbull.2018.08.020 Impact Factor 3.07
  10. Sheikh F. Ahmad, Mushtaq A. Ansari, Ahmed Nadeem, Saleh A. Bakheet, Musaad A. Alshammari, Sabry M. Attiaab (2018). The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model. Neurochemistry International. doi.org/10.1016/j.neuint.2018.09.006 Impact Factor 3.40
  11. Syed R Ali, Zhiqing Liu, Miroslav N. Nenov, Oluwarotimi Folorunso, Aditya Kumar Singh, Federico Scala, Haiying Chen, T. F. James, Musaad Alshammari, Neli I. Panova-Elektronova, Mark Andrew White, Jia Zhou, and Fernanda Laezza (2018). Functional modulation of voltage-gated sodium channels by a FGF14-based peptidomimetic. ACS Chem. Neurosci. doi: 10.1021/acschemneuro.7b00399 Impact Factor 4.62
  12. AR Alhoshani, MM Hafez, S Husain, AM Al-sheikh, MR Alotaibi, SS Al Rejaie, MA Alshammari, MM Almutairi, OA Al-Shabanah (2017). Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats. BMC Nephrology. doi: 10.1038/tp.2016.66  Impact Factor 2.5 dio: 10.1186/s12882-017-0601-y
  13. Tahani K. Alshammari#, Musaad A. Alshammari#, Miroslav N. Nenov, Eriola Hoxha, Marco Cambiaghi, Andrea Marcinno`, Thomas F. James, Pankaj Singh, Demetrio Labate, Jiang Li, Herbert Y. Meltzer, Benedetto Sacchetti, Filippo Tempia, and Fernanda Laezza (2016). Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia. Translational Psychiatry. doi: 10.1038/tp.2016.66 #Equally contributed Impact Factor 5.47
  14. Musaad A. Alshammari, Tahani K. Alshammari, and Fernanda Laezza (2016). Improved methods for fluorescence microscopy detection of macromolecules at the axon initial segment. Frontiers in Cellular Neuroscience. doi: 10.3389/fncel.2016.00005  Impact Factor 4.91
  15. Musaad A. Alshammari, Tahani K. Alshammari, Miroslav N. Nenov, Federico Scala, Fernanda Laezza (2015). Fibroblast Growth Factor 14 Modulates the Neurogenesis of Granule Neurons in the Adult Dentate Gyrus. Molecular Neurobiology. doi: 10.​1007/​s12035-015-9568-5. Impact Factor 5.13
  16. Filippo Tempia, Eriola Hoxha, Giulia Negro, Musaad A. Alshammari, Tahani K. Alshammari, Neli Panova-Elektronova and Fernanda Laezza (2015). Parallel fiber to Purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27Frontiers in Cellular Neuroscience. doi: 10.3389/fncel.2015.00205. Impact Factor 4.91

 

  1. CONFERENCE PROCEEDINGS
  1. Tahani K Alshammari, Musaad A Alshammari, Miroslav Nenov, Jiang Li, Herbert Y Meltzer, Fernanda Laezza (2016). “Proteomic and Bioinformatic Pipeline to Uncover Novel Pathways and Targets in Psychiatric Illness”, in: Society of Biological Psychiatry (SOBP) 71st Annual Meeting May 12-14, 2016, Hyatt Regency Downtown, Atlanta, Georgia. Biological Psychiatry, Volume: 79 Issue: 9 Pages: 289S-289S Supplement: S Meeting Abstract: 873.  Impact Factor 10.885
  2. Alshammari, T. K., Alshammari, M. A., Nenov, M. N., Hoxha, E., Cambiaghi, M., Marcinnò, A., James, T. F., Singh, P., Labate, D., Li, J., Meltzer, H. Y., Sacchetti, B., Tempia, F., and Laezza, F. (2015). "Fibroblast Growth Factor 14 is an Essential Element of the Inhibitory Circuit that Controls Cognitive Function Associated with Schizophrenia", in: American College of Neuropsychopharmacology (ACNP) 54th Annual Meeting, eds. R.E. Gur, B. Moghaddam & C. A. Zarate: Neuropsychopharmacology, S443-S611. doi:10.1038/npp.2015.327. Impact Factor 6.782

 ABSTRACTS

  1. Alshammari, M. A., Alshammari, T. K., Di Re, J., Laezza, J. Disruption of the axonal initial segment composition in schizophrenia. Society for Neuroscience (SfN). Nov. 2018. San Diego, CA.
  2. Abdulaziz O. Alshehri, Abdullah M. Albogami, Yousef H. Alotibi, Malika J. Alhadab, Musaad A. Alshammari. The axon initial segment (AIS) architecture in an autistic mouse model. Saudi International Pharmaceutical Sciences Meeting and Workshop (SIPHA), Feb.19th, 2018, Riyadh, Saudi Arabia.
  3. Alshammari, M. A., Khan, M. R., Alhosaini, K. A., Ali, R., Boudjelal, M., Alshammari, T. K. The architecture and development of the axon initial segment (AIS) in an autistic mouse model. Society for Neuroscience (SfN). Nov. 2017. Washington, DC
  4. Nenov, M. N., Hsu, W. C, Alshammari, M. A., Folorunso, O., Panova, N. I, Laezza, F. Akt regulates neuronal excitability by modulating Nav1.6 sodium channel. Society for Neuroscience (SfN). Nov. 2017. Washington, DC
  5. Alshammari, M. A., Alshammari, T. K., Scala, F., Nenov, M. N., Laezza, F. FGF14 is a master organizer of the beta-IV spectrin complex at the axonal initial segment and the paranodal junction in cortical regions. Society for Neuroscience (SfN). Nov. 15th, 2016. San Diego, CA.
  6. Alshammari T. K., Alshammari M. A., Nenov M. N., Hoxha E., Tempia F., Laezza F. Genetic deletion of Fgf14 disrupts inhibitory connections of the brain hippocampal region in a sex specific manner. Nov. 14th, 2016. San Diego, CA.
  7. Scala F., Nenov M. N., Crofton E., Zhang Y., Wildburger N., Chesson B., James T., Alshammari M., Alshammari T., Litchi C., Rudra J., D'ascenzo M., Green T., Laezza F. GSK3 signaling regulates intrinsic firing and persistent sodium current in medium spiny neurons of the nucleus accumbens. Nov. 15th, 2016. San Diego, CA
  8. Alshammari, M. A., Alshammari, T. K., Scala, F., Nenov, M. N., Laezza, F. Genetic deletion of intracellular fibroblast growth factor 14 (fgf14) disrupts transition of late immature to mature newly born granule neurons in the adult dentate gyrus. 19th Annual Forum on Aging, University of Texas Medical Branch. Oct. 23rd 2015. Galveston, TX.
  9. Alshammari, T. K., Alshammari, M. A., Hoxha, E., Nenov, M. N., Cambiaghi, M., Marcinno, A., James, T. F., Li, J., Sacchetti, B., Meltzer, H. Y., Tempia, F., Laezza, F. Disruption of the hippocampal gabaergic system in the fgf14–/– mouse model. 19th Annual Forum on Aging, University of Texas Medical Branch. Oct. 23rd 2015. Galveston, TX.
  10. Alshammari, M. A., Alshammari, T. K., Scala, F., Nenov, M. N., Laezza, F. Genetic deletion of intracellular fibroblast growth factor 14 (fgf14) disrupts transition of late immature to mature newly born granule neurons in the adult dentate gyrus. Society for Neuroscience (SfN). Oct. 21st 2015. Chicago, IL
  11. Alshammari, T. K., Alshammari, M. A., Hoxha, E., Nenov, M. N., Cambiaghi, M., Marcinno, A., James, T. F., Li, J., Sacchetti, B., Meltzer, H. Y., Tempia, F., Laezza, F. Disruption of the hippocampal gabaergic system in the fgf14–/– mouse model. Society for Neuroscience (SfN). Oct. 20th 2015. Chicago, IL Awarded for SFN Trainee Professional Development Award.
  12. Scala, F., Nenov, M. N., Alshammari, M. A., James, T. F., Panova-Elektronova, N., Grassi, C., D'ascenzo, M., Laezza, F. Triciribine potentiates Nav1.6-encoded currents and increases excitability of medium spiny neurons in the nucleus accumbens. Society for Neuroscience (SfN). Oct.17th 2015. Chicago, IL
  13. Alshammari, M. A., Alshammari, T. K, Nenov, M. N., Scala, F., Laezza, F. FGF14 is Required for Neurogenesis of Granule Neurons in the Adult Dentate Gyrus. Neuro Regeneration Collaborative Symposium, BioScience Research Collaborative, Rice University. Sep. 2015. Houston, TX Awarded for the First Prize award.
  14. Alshammari, T., Alshammari, M., Nenov, M., Hoxha, E., James, T., Cambiaghi, M., Sacchetti, B., Tempia, F., Laezza, F. Role   of   FGF14   in   the   Inhibitory   Circuitry   Underlying Cognitive Processing. American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. Jun. 2015. Miami, FL
  15. Alshammari, M., Alshammari, T., Laezza, F. Regulation of adult neurogenesis by FGF14 as a potential mechanistic link to human brain disorders. 20th Annual Sealy Center for Structural Biology Symposium, University of Texas Medical Branch. May 2015. Galveston, TX
  16. Alshammari, T., Alshammari, M., Nenov, M., Hoxha, E., Marcinno, A., Cambiaghi, M. James, T., Sacchetti, B., Tempia, F., Laezza, F. Genetic deletion of Fgf14 recapitulates molecular, cellular and circuit alterations underlying cognitive impairment associated with human psychiatric disorders. 20th Annual Sealy Center for Structural Biology Symposium, University of Texas Medical Branch. May 2015. Galveston, TX
  17. Alshammari, M., Alshammari, T., Laezza, F. Regulation of adult neurogenesis by FGF14 as a potential mechanistic link to human brain disorders. UT Austin Conference on Learning & Memory, the University of Texas at Austin. Apr. 2015. Austin, TX Selected for travel award.
  18. Alshammari, T., Alshammari, M., Nenov, M., Hoxha, E., Marcinno, A., Cambiaghi, M. James, T., Sacchetti, B., Tempia, F., Laezza, F. Genetic deletion of Fgf14 recapitulates molecular, cellular and circuit alterations underlying cognitive impairment associated with human psychiatric disorders. UT Austin Conference on Learning & Memory, the University of Texas at Austin. Apr. 2015. Austin, TX Selected for travel award.
  19. Nenov, M., Crofton, E., Scala, F., Zhang, Y., Alshammari, M., Alshammari, T., D’Ascenzo, M., Green, T., Laezza, F. Identification of Akt-GSK3-Nav1.6 sodium channel signaling pathway as a therapeutic target against psychiatric disorders. UT Austin Conference on Learning & Memory, the University of Texas at Austin. Apr. 2015. Austin, TX
  20. Alshammari, M., Alshammari, T., Panova-Elektronova, N., Laezza, F. Regulation of Adult Hippocampal Neurogenesis by FGF14. University of Texas Medical Branch 3rd Annual Clinical & Translational Research Forum. Mar. 2015. Galveston, TX
  21. Alshammari, T., Alshammari, M., Laezza, F. Genetic deletion of Fgf14 disrupts inhibitory connections of the brain hippocampal region in a sex-specific manner. University of Texas Medical Branch 3rd Annual Clinical & Translational Research Forum. Mar. 2015. Galveston, TX
  22. Nenov, M., Crofton, E., Scala, F., Zhang, Y., Alshammari, M., Alshammari, T., D’Ascenzo, M., Green, T., Laezza, F. Identification of Akt-GSK3-Nav1.6 sodium channel signaling pathway as a therapeutic target against psychiatric disorders. University of Texas Medical Branch 3rd Annual Clinical & Translational Research Forum. Mar. 2015. Galveston, TX
  23. Laezza, F., Negro, G., Alshammari, M., Alshammari, T., Tempia, F. Parallel fiber to Purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27. Society for Neuroscience (SfN). Nov. 2014. Washington, DC
  24.  Nenov, M., Crofton, E., Scala, F., Zhang, Y., Alshammari, M., Alshammari, T., D’Ascenzo, M., Green, T., Laezza, F. Identification of Akt-GSK3-Nav1.6 sodium channel signaling pathway as a therapeutic target against psychiatric disorders. Society for Neuroscience (SfN). Nov. 2014. Washington, DC

ORAL PRESENTATIONS:

  1. Invited Speaker: Musaad Alshammari. Image analysis for publication. AAPS-SD Pharmaceutical Sciences Research Workshop, Marriott Hotel, Riyadh, Saudi Arabia. Oct. 12th, 2019
  2. Invited Speaker: Musaad Alshammari. Establishing an Institutional Basic Sciences Research units: institutional experience. Saudi International Pharmaceutical Sciences Meeting and Workshop (SIPHA), The Ritz-Carlton, Jeddah, Saudi Arabia. Jan. 24th, 2019 
  3. Musaad Alshammari. Cellular Alterations of Adult Hippocampal Neurogenesis in The Fgf14−/− Mouse Model. Pharmacology and Toxicology Seminar Series, Pharmacology & Toxicology Department, King Saud University, Riyadh, Saudi Arabia, April 12th, 2017
  4. Musaad Alshammari. FGF14 is Required for Late Immature to Mature Transition of Newly Born Granule Neurons in the Adult Dentate Gyrus. Pharmacology and Toxicology Student Summer Seminar Series, Pharmacology & Toxicology Department, University of Texas Medical Branch, Galveston, Jun 5th, 2015.
  5. Musaad Alshammari. FGF14: A New Regulator of the DISC1 Pathway Affecting Adult Hippocampal Neurogenesis. Qualifying Proposal Seminar, Pharmacology & Toxicology Department, University of Texas Medical Branch, Galveston, Jun 20th, 2014.
  6. Musaad Alshammari. The mechanisms underlying loss of GABAergic synaptic transmission in Fgf14-/- mouse model. Pharmacology and Toxicology Student Summer Seminar Series, Pharmacology & Toxicology Department, University of Texas Medical Branch, Galveston, Jul. 3rd, 2013.

TV INTERVIEW

  1. The "MBC in Week" program on MBC, presented by the Saudi journalist Ali Algofaily, interview addressed Antibiotics Resistance.  (April. 13th, 2019)
  2. The "ALTHAMENH" program on MBC, presented by the Saudi journalist Dawood Al-Shorian, one-hour interview addressed drug of abuse issues in Saudi Society.  (Oct. 2nd, 2016)

TRAINING, WORKSHOPS, AND CONTINUING EDUCATION PROGRAMS:

  1. Strategic management, The National Center for Performance Measurement "Adaa", King Saud University, Riyadh, Saudi Arabia. (Nov. 17-19, 2019)
  2. The 5th Forum and Training Course for Local Ethics Committee (IRB), National Committee of Bioethics (NCBE), King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia. (Sep. 12th, 2019)
  3. Workshop on Advanced Transcriptomics (RNASeq) Analysis, National Institutes of Health (NIH Campus), Bethesda, Maryland (Jun 17 - 20 2019)
  4. Workshop on Techniques Modeling Human Cancer in Mice, The Jackson Laboratory, Bar Harbor, ME. (Aug 20 - 26, 2017)
  5. New King Saud University Faculty Training, King Saud University, Riyadh, Saudi Arabia. (Dec. 5-6th, 2016)
  6. Enhancing teaching and student learning (Mentoring Faculty), King Saud University, Riyadh, Saudi Arabia. (Sep. 29th, 2016
  7. Animal Facility Designs for Biocontainment, AALAS Learning Library. University of Texas Medical Branch, Galveston, TX. (Oct. 16th, 2016)
  8. Genetics: The Basics, AALAS Learning Library. University of Texas Medical Branch, Galveston, TX. (Oct. 16th, 2016)
  9. Scientific Writing for Translational Research. Institute for Translational Sciences, University of Texas Medical Branch. (Feb. 18-27th, 2015)
  10. Pain Recognition and Alleviation in Laboratory Animals, AALAS Learning Library. University of Texas Medical Branch, Galveston, TX. (Oct. 25th, 2011)
  11. Euthanasia of Research Animals: AVMA Guidelines, AALAS Learning Library. University of Texas Medical Branch, Galveston, TX. (Oct. 25th, 2011)
  12. Biosafety Program (Training for the Safe Use, Handling and Storage of Biological Agents) University of Texas Medical Branch, Galveston, TX. (Fall 2011)

CONFERENCES AND SYMPOSIA ATTENDED:

  1. 9th College of Pharmacy Research Day (Oral Presentation Judge), King Saud University, Riyadh, Saudi Arabia. (Apr. 11, 2019)
  2. Saudi International Pharmaceutical Sciences Meeting and Workshop (SIPHA), The Ritz-Carlton, Jeddah, Saudi Arabia. (Jan. 23-24, 2019)
  3. 8th College of Pharmacy Research Day, King Saud University, Riyadh, Saudi Arabia. (Apr. 10-11, 2018)
  4. Saudi International Pharmaceutical Sciences Meeting and Workshop (SIPHA), Alfysalliah Hotel, Riyadh, Saudi Arabia. (Feb.19-20, 2018)
  5. Society for Neuroscience (SfN) 2015 annual meeting. Chicago, IL, USA. (Oct. 17-21, 2015)
  6. NeuroRegeneration Collaborative Symposium, Bioscience Research Collaborative, Rice University, Houston, TX, USA. (Sep. 1-2, 2015)
  7. 20th Annual Sealy Center for Structural Biology Symposium, the University of Texas Medical Branch, Galveston, TX, USA. (May 2, 2015)
  8. UT Austin Conference on Learning & Memory, the University of Texas at Austin, Austin, TX, USA. (Apr. 24-25, 2015)
  9. 3rd Annual Clinical & Translational Research Forum, the University of Texas Medical Branch, Galveston, TX, USA. (Mar.11, 2015)
  10. Society for Neuroscience (SfN) 2014 annual meeting. Washington, DC, USA. (Nov.15-19, 2014)
  11. GABAergic Signaling in Health and Disease, 24th Neuropharmacology Conference, Sheraton Pentagon City, Arlington, VA, USA. (Nov.13-14, 2014)
  12. Miami 2014 Winter Symposium, The Molecular Basis of Brain Disorders. Miami, FL, USA. (Jan.26-29, 2014)
  13. The national pharmacovigilance center launching. Drug safety a global concern. Riyadh, Saudi Arabia. (Mar.30-31, 2009)
  14. Updates in sterile compounding and parental nutrition symposium. King Fahd medical city, Riyadh, Saudi Arabia. (Jul.21-22, 2008)
  15. The 7th international Saudi pharmaceutical conference which was held in Prince Sultan hall, Alfysalliah Hotel, Riyadh, Saudi Arabia. (Mar.19-21, 2007)
  16. The 9th international pharmaceutical sciences conference. King Saud University College of pharmacy, Riyadh, Saudi Arabia. (Dec.17-21, 2005)
  17. The 6th Saudi Pharmaceutical International Conference, Pharmacy Profession Towards Patient Care. Riyadh, Saudi Arabia (Oct.6-9, 2003)